
- Volume 0 0
OMACOR AND AMICAR STILL ARE BEING CONFUSED
Reliant Pharmaceuticals Inc has warned pharmacistsabout recent confusion between its Omacor(omega-3-acid ethyl esters) capsules and XanodynePharmaceuticals Inc's Amicar (aminocaproic acid)tablets. Omacor's manufacturer has informed pharmaciststhat telephone orders for its drug continueto be "misunderstood and dispensed" as Amicar.
FDA-approved Omacor is indicated as an adjunct to diet for thereduction of very high triglyceride levels. Amicar, however, is indicatedfor enhancing hemostasis when fibrinolysis contributes to bleeding.In certain patients, Amicar is prescribed for oral use to controlacute or chronic bleeding syndromes.
Reliant issued a similar warning in November 2005. The companysaid that it was developing a "shelf talker" for pharmacists "to helpprevent any more medication errors." For more information, visitwww.omacorrx.com.
Articles in this issue
almost 20 years ago
Should Pharmacists Receive Overtime Pay?almost 20 years ago
Pharmacists—Cops or Not? (Part 2)almost 20 years ago
canyouREADtheseRxs?almost 20 years ago
compoundingHOTLINEalmost 20 years ago
NSAIDs and Antihypertensive Agentsalmost 20 years ago
FDA Approves New Constipation Drugalmost 20 years ago
Angina Drug Approvedalmost 20 years ago
Pancreatic Cancer Trials Offer Positive Resultsalmost 20 years ago
Cancer Drug Receives Approval for 2 Conditionsalmost 20 years ago
Long-term LNG/EE Use Does Not Hinder Future OvulationNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


























